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ABSTRCT 
The humoral immune responses against 46 different staphylococcal antigens in 27 bacteremia 
patients infected by clonally related methicillin-resistant Staphylococcus aureus (MRSA) strains 
of a single sequence type (ST) 239 were investigated. A group of non-infected patients (n = 31) 
hospitalized for different reasons served as controls. All strains were confirmed as ST 239 by S. 
aureus and mecA-specific PCR, spa, and multi-locus sequence typing (MLST). In each 
bacteremia patient, a unique pattern of S. aureus antigen-specific immune responses after 
infection was observed. Antibody levels among bacteremia patients were significantly higher 
than controls for HlgB (P = 0.001), LukD (P = 0.009), LukF (P = 0.0001), SEA (P = 0.0001), 
SEB (P = 0.011), SEC (P = 0.010), SEQ (P = 0.049), IsaA (P = 0.043), IsdA (P = 0.038), IsdH (P 
= 0.01), SdrD (P = 0.001), SdrE (P = 0.046), EsxA (P = 0.0001), and SA0104 (P = 0.0001). On 
the other hand, the antibody levels were significantly higher among controls for SSL3 (P = 
0.009), SSL9 (P = 0.002), and SSL10 (P = 0.007) when the IgG level on the day of infection was 
compared with that measured on the day of admission. Diversity was observed in the immune 
response against the antigens. However, a set of antigens (IsaA, IsdA, IsdH, SdrD, and HlgB) 
triggered a similar type of immune response in different individuals. We suggest that these 
antigens could be considered when developing a multi-component (passive) vaccine. SEA and/or 
its specific antibodies seem to play a critical role during ST239 MRSA bacteremia and SEA-
targeted therapy may be a strategy to be considered. 
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